Cisplatin suppresses Slc25a21 expression in tubular cells, leading to a disturbance in mitochondrial homeostasis and subsequent cell apoptosis, necroptosis as well as inflammation, contributing to AKI progression. This evidence concerns the gene SLC25A21 and acute kidney injury.